uuid stringlengths 4 8 | template_uuid stringclasses 40
values | question stringlengths 13 193 | answer stringlengths 29 2.2k | benchmark_query stringlengths 133 622 | execution_results stringlengths 2 1.14M | query_type stringclasses 2
values | sql_category stringclasses 26
values | bio_category stringclasses 14
values |
|---|---|---|---|---|---|---|---|---|
Q19.50 | Q19 | Which SNP is most significantly associated with FTD in the Cerebellum? | There are no significantly associated SNPs with FTD in the Cerebellum. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'cerebellum' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.36 | Q19 | Which SNP is most significantly associated with ALS in the Nucleus Accumbens Basal? | There are no significantly associated SNPs with ALS in the Nucleus Accumbens Basal. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'nucleus accumbens basal' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.17 | Q19 | Which SNP is most significantly associated with AD in the Skeletal Muscle? | The most significantly associated SNP with AD in the Skeletal Muscle is rs4510068, located in the LRRC37A2 gene, with an adjusted SMR multi-SNP P-value of 1.15e-07 and a HEIDI value of 4.0087e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'skeletal muscle' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1343161', 'topRSID': 'rs4510068', 'Disease': 'AD', 'Omic_tissue': 'Skeletal Muscle', 'p_SMR_multi': 1.152517e-07, 'p_HEIDI': 0.4008675, 'A1': 'T', 'A2': 'G', 'Freq': 0.428425, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.72 | Q19 | Which SNP is most significantly associated with LBD in the Cerebral Spinal Fluid? | There are no significantly associated SNPs with LBD in the Cerebral Spinal Fluid. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'cerebral spinal fluid' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.35 | Q19 | Which SNP is most significantly associated with ALS in the Multi Ancestry Whole Brain? | There are no significantly associated SNPs with ALS in the Multi Ancestry Whole Brain. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'multi ancestry whole brain' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.86 | Q19 | Which SNP is most significantly associated with LBD in the Whole Blood? | The most significantly associated SNP with LBD in the Whole Blood is rs2301134, located in the SNCA gene, with an adjusted SMR multi-SNP P-value of 3.12e-10 and a HEIDI value of 8.6050e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'whole blood' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_934862', 'topRSID': 'rs2301134', 'Disease': 'LBD', 'Omic_tissue': 'Whole Blood', 'p_SMR_multi': 3.123872e-10, 'p_HEIDI': 0.8604982, 'A1': 'A', 'A2': 'G', 'Freq': 0.513292, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.8 | Q19 | Which SNP is most significantly associated with AD in the Cortex? | The most significantly associated SNP with AD in the Cortex is rs1830763, located in the CR1 gene, with an adjusted SMR multi-SNP P-value of 3.83e-15 and a HEIDI value of 6.0285e-02. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'cortex' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1105231', 'topRSID': 'rs1830763', 'Disease': 'AD', 'Omic_tissue': 'Cortex', 'p_SMR_multi': 3.826448e-15, 'p_HEIDI': 0.06028479, 'A1': 'A', 'A2': 'C', 'Freq': 0.821063, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.44 | Q19 | Which SNP is most significantly associated with ALS in the Whole Brain? | There are no significantly associated SNPs with ALS in the Whole Brain. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'whole brain' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.123 | Q19 | Which SNP is most significantly associated with PSP in the Skeletal Muscle? | There are no significantly associated SNPs with PSP in the Skeletal Muscle. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'skeletal muscle' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.120 | Q19 | Which SNP is most significantly associated with PSP in the Multi Ancestry Whole Brain? | There are no significantly associated SNPs with PSP in the Multi Ancestry Whole Brain. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'multi ancestry whole brain' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.109 | Q19 | Which SNP is most significantly associated with PSP in the Amygdala? | The most significantly associated SNP with PSP in the Amygdala is rs393152, located in the ARL17A gene, with an adjusted SMR multi-SNP P-value of 6.08e-09 and a HEIDI value of 6.8247e-02. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'amygdala' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1604720', 'topRSID': 'rs393152', 'Disease': 'PSP', 'Omic_tissue': 'Amygdala', 'p_SMR_multi': 6.079622e-09, 'p_HEIDI': 0.06824737, 'A1': 'G', 'A2': 'A', 'Freq': 0.237219, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.9 | Q19 | Which SNP is most significantly associated with AD in the Frontal Cortex? | The most significantly associated SNP with AD in the Frontal Cortex is rs4074462, located in the LRRC37A2 gene, with an adjusted SMR multi-SNP P-value of 1.50e-06 and a HEIDI value of 8.1756e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'frontal cortex' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1157207', 'topRSID': 'rs4074462', 'Disease': 'AD', 'Omic_tissue': 'Frontal Cortex', 'p_SMR_multi': 1.497902e-06, 'p_HEIDI': 0.817564, 'A1': 'T', 'A2': 'G', 'Freq': 0.236196, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.14 | Q19 | Which SNP is most significantly associated with AD in the Nucleus Accumbens Basal? | The most significantly associated SNP with AD in the Nucleus Accumbens Basal is rs2070215, located in the STAG3 gene, with an adjusted SMR multi-SNP P-value of 1.58e-08 and a HEIDI value of 1.8185e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'nucleus accumbens basal' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1716109', 'topRSID': 'rs2070215', 'Disease': 'AD', 'Omic_tissue': 'Nucleus Accumbens Basal', 'p_SMR_multi': 1.584787e-08, 'p_HEIDI': 0.181851, 'A1': 'C', 'A2': 'T', 'Freq': 0.269939, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.91 | Q19 | Which SNP is most significantly associated with PD in the Caudate Basal Ganglia? | The most significantly associated SNP with PD in the Caudate Basal Ganglia is rs55974014, located in the RP11-259G18.3 gene, with an adjusted SMR multi-SNP P-value of 1.39e-12 and a HEIDI value of 2.2080e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PD' AND LOWER(Omic_tissue) = 'caudate basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1281357', 'topRSID': 'rs55974014', 'Disease': 'PD', 'Omic_tissue': 'Caudate Basal Ganglia', 'p_SMR_multi': 1.387203e-12, 'p_HEIDI': 0.2207953, 'A1': 'A', 'A2': 'C', 'Freq': 0.226994, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.4 | Q19 | Which SNP is most significantly associated with AD in the Caudate Basal Ganglia? | The most significantly associated SNP with AD in the Caudate Basal Ganglia is rs1628077, located in the PVRIG gene, with an adjusted SMR multi-SNP P-value of 2.97e-08 and a HEIDI value of 1.0856e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'caudate basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1266779', 'topRSID': 'rs1628077', 'Disease': 'AD', 'Omic_tissue': 'Caudate Basal Ganglia', 'p_SMR_multi': 2.967177e-08, 'p_HEIDI': 0.1085551, 'A1': 'A', 'A2': 'G', 'Freq': 0.263804, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.18 | Q19 | Which SNP is most significantly associated with AD in the Spinalcord? | There are no significantly associated SNPs with AD in the Spinalcord. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'spinalcord' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.39 | Q19 | Which SNP is most significantly associated with ALS in the Skeletal Muscle? | There are no significantly associated SNPs with ALS in the Skeletal Muscle. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'skeletal muscle' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.74 | Q19 | Which SNP is most significantly associated with LBD in the Frontal Cortex? | There are no significantly associated SNPs with LBD in the Frontal Cortex. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'frontal cortex' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.114 | Q19 | Which SNP is most significantly associated with PSP in the Cerebellum? | There are no significantly associated SNPs with PSP in the Cerebellum. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'cerebellum' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.7 | Q19 | Which SNP is most significantly associated with AD in the Cerebral Spinal Fluid? | There are no significantly associated SNPs with AD in the Cerebral Spinal Fluid. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'AD' AND LOWER(Omic_tissue) = 'cerebral spinal fluid' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.119 | Q19 | Which SNP is most significantly associated with PSP in the Liver? | The most significantly associated SNP with PSP in the Liver is rs11869096, located in the RP11-798G7.8 gene, with an adjusted SMR multi-SNP P-value of 3.85e-07 and a HEIDI value of 2.8696e-02. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'liver' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1478183', 'topRSID': 'rs11869096', 'Disease': 'PSP', 'Omic_tissue': 'Liver', 'p_SMR_multi': 3.852944e-07, 'p_HEIDI': 0.02869639, 'A1': 'A', 'A2': 'G', 'Freq': 0.441718, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.111 | Q19 | Which SNP is most significantly associated with PSP in the Basal Ganglia? | There are no significantly associated SNPs with PSP in the Basal Ganglia. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.103 | Q19 | Which SNP is most significantly associated with PD in the Skeletal Muscle? | The most significantly associated SNP with PD in the Skeletal Muscle is rs12947718, located in the PLEKHM1 gene, with an adjusted SMR multi-SNP P-value of 7.76e-12 and a HEIDI value of 3.5360e-02. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PD' AND LOWER(Omic_tissue) = 'skeletal muscle' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1370536', 'topRSID': 'rs12947718', 'Disease': 'PD', 'Omic_tissue': 'Skeletal Muscle', 'p_SMR_multi': 7.763854e-12, 'p_HEIDI': 0.03535971, 'A1': 'A', 'A2': 'G', 'Freq': 0.193252, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.55 | Q19 | Which SNP is most significantly associated with FTD in the Liver? | There are no significantly associated SNPs with FTD in the Liver. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'liver' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.51 | Q19 | Which SNP is most significantly associated with FTD in the Cortex? | There are no significantly associated SNPs with FTD in the Cortex. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'cortex' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.87 | Q19 | Which SNP is most significantly associated with LBD in the Whole Brain? | The most significantly associated SNP with LBD in the Whole Brain is rs59007384, located in the TOMM40 gene, with an adjusted SMR multi-SNP P-value of 4.14e-08 and a HEIDI value of 5.3022e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'whole brain' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_402972', 'topRSID': 'rs59007384', 'Disease': 'LBD', 'Omic_tissue': 'Whole Brain', 'p_SMR_multi': 4.137428e-08, 'p_HEIDI': 0.5302237, 'A1': 'G', 'A2': 'T', 'Freq': 0.787321, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.47 | Q19 | Which SNP is most significantly associated with FTD in the Basal Ganglia? | There are no significantly associated SNPs with FTD in the Basal Ganglia. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.118 | Q19 | Which SNP is most significantly associated with PSP in the Hypothalamus? | There are no significantly associated SNPs with PSP in the Hypothalamus. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'hypothalamus' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.63 | Q19 | Which SNP is most significantly associated with FTD in the Tibial Nerve? | There are no significantly associated SNPs with FTD in the Tibial Nerve. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'tibial nerve' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.125 | Q19 | Which SNP is most significantly associated with PSP in the Substantia nigra? | There are no significantly associated SNPs with PSP in the Substantia nigra. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'substantia nigra' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.81 | Q19 | Which SNP is most significantly associated with LBD in the Putamen Basal Ganglia? | There are no significantly associated SNPs with LBD in the Putamen Basal Ganglia. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'putamen basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.102 | Q19 | Which SNP is most significantly associated with PD in the Putamen Basal Ganglia? | The most significantly associated SNP with PD in the Putamen Basal Ganglia is rs55974014, located in the KANSL1-AS1 gene, with an adjusted SMR multi-SNP P-value of 1.42e-12 and a HEIDI value of 4.0248e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PD' AND LOWER(Omic_tissue) = 'putamen basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1594924', 'topRSID': 'rs55974014', 'Disease': 'PD', 'Omic_tissue': 'Putamen Basal Ganglia', 'p_SMR_multi': 1.416904e-12, 'p_HEIDI': 0.4024768, 'A1': 'A', 'A2': 'C', 'Freq': 0.226994, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.42 | Q19 | Which SNP is most significantly associated with ALS in the Tibial Nerve? | There are no significantly associated SNPs with ALS in the Tibial Nerve. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'tibial nerve' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.60 | Q19 | Which SNP is most significantly associated with FTD in the Skeletal Muscle? | There are no significantly associated SNPs with FTD in the Skeletal Muscle. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'skeletal muscle' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.92 | Q19 | Which SNP is most significantly associated with PD in the Cerebellar Hemisphere? | The most significantly associated SNP with PD in the Cerebellar Hemisphere is rs55974014, located in the RP11-259G18.3 gene, with an adjusted SMR multi-SNP P-value of 6.75e-12 and a HEIDI value of 1.6448e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PD' AND LOWER(Omic_tissue) = 'cerebellar hemisphere' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1191174', 'topRSID': 'rs55974014', 'Disease': 'PD', 'Omic_tissue': 'Cerebellar Hemisphere', 'p_SMR_multi': 6.749073e-12, 'p_HEIDI': 0.1644817, 'A1': 'A', 'A2': 'C', 'Freq': 0.226994, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.49 | Q19 | Which SNP is most significantly associated with FTD in the Cerebellar Hemisphere? | There are no significantly associated SNPs with FTD in the Cerebellar Hemisphere. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'cerebellar hemisphere' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.90 | Q19 | Which SNP is most significantly associated with PD in the Basal Ganglia? | The most significantly associated SNP with PD in the Basal Ganglia is rs199530, located in the LRRC37A2 gene, with an adjusted SMR multi-SNP P-value of 5.01e-10 and a HEIDI value of 1.0354e-02. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PD' AND LOWER(Omic_tissue) = 'basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_27185', 'topRSID': 'rs199530', 'Disease': 'PD', 'Omic_tissue': 'Basal Ganglia', 'p_SMR_multi': 5.010068e-10, 'p_HEIDI': 0.01035425, 'A1': 'G', 'A2': 'A', 'Freq': 0.256646, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.110 | Q19 | Which SNP is most significantly associated with PSP in the Anterior Cingulate Cortex BA24? | The most significantly associated SNP with PSP in the Anterior Cingulate Cortex BA24 is rs11012, located in the PLEKHM1 gene, with an adjusted SMR multi-SNP P-value of 8.50e-08 and a HEIDI value of 4.8750e-01. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'anterior cingulate cortex ba24' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [{'UUID': 'NDD_SMR_genes_all_update_text_1489532', 'topRSID': 'rs11012', 'Disease': 'PSP', 'Omic_tissue': 'Anterior Cingulate Cortex BA24', 'p_SMR_multi': 8.497756e-08, 'p_HEIDI': 0.487497, 'A1': 'T', 'A2': 'C', 'Freq': 0.191207, 'func_sig': 'functionally significant'}] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.59 | Q19 | Which SNP is most significantly associated with FTD in the Putamen Basal Ganglia? | There are no significantly associated SNPs with FTD in the Putamen Basal Ganglia. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'putamen basal ganglia' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.77 | Q19 | Which SNP is most significantly associated with LBD in the Liver? | There are no significantly associated SNPs with LBD in the Liver. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'LBD' AND LOWER(Omic_tissue) = 'liver' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.33 | Q19 | Which SNP is most significantly associated with ALS in the Hypothalamus? | There are no significantly associated SNPs with ALS in the Hypothalamus. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'ALS' AND LOWER(Omic_tissue) = 'hypothalamus' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.121 | Q19 | Which SNP is most significantly associated with PSP in the Nucleus Accumbens Basal? | There are no significantly associated SNPs with PSP in the Nucleus Accumbens Basal. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'PSP' AND LOWER(Omic_tissue) = 'nucleus accumbens basal' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.61 | Q19 | Which SNP is most significantly associated with FTD in the Spinalcord? | There are no significantly associated SNPs with FTD in the Spinalcord. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'spinalcord' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q19.65 | Q19 | Which SNP is most significantly associated with FTD in the Whole Brain? | There are no significantly associated SNPs with FTD in the Whole Brain. | SELECT UUID, topRSID, Disease, Omic_tissue, p_SMR_multi, p_HEIDI, A1, A2, Freq, func_sig
FROM `{project_id}.{dataset_name}.NeurodegenerativeDiseases_SMR_Genes_Full`
WHERE Disease = 'FTD' AND LOWER(Omic_tissue) = 'whole brain' AND p_SMR_multi < 2.95e-6 AND p_HEIDI > 0.01
ORDER BY p_SMR_multi
LIMIT 1 | [] | refined | Select, Multi-Filter, Order By, Threshold | Functional Significance |
Q2.589 | Q2 | What is the allele frequency of the SNP rs148297753 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs148297753 has an effect allele T frequency of 0.0211 and non-effect allele C frequency of 0.9789. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs148297753"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_2213102', 'SNP': 'rs148297753', 'effect_allele': 'T', 'effect_allele_frequency': 0.0211, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9789}] | general | Calculate, Select | Allele Frequency |
Q2.1868 | Q2 | What is the allele frequency of the SNP rs12878970 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs12878970 has an effect allele T frequency of 0.4998 and non-effect allele C frequency of 0.5002. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs12878970"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7272064', 'SNP': 'rs12878970', 'effect_allele': 'T', 'effect_allele_frequency': 0.4998, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.5002}] | general | Calculate, Select | Allele Frequency |
Q2.1061 | Q2 | What is the allele frequency of the SNP rs2852094 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2852094 has an effect allele G frequency of 0.2039 and non-effect allele A frequency of 0.7961. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs2852094"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4082181', 'SNP': 'rs2852094', 'effect_allele': 'G', 'effect_allele_frequency': 0.2038999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.7961000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1084 | Q2 | What is the allele frequency of the SNP rs9662572 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs9662572 has an effect allele G frequency of 0.3061 and non-effect allele A frequency of 0.6939. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs9662572"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4180685', 'SNP': 'rs9662572', 'effect_allele': 'G', 'effect_allele_frequency': 0.3061, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.6939}] | general | Calculate, Select | Allele Frequency |
Q2.925 | Q2 | What is the allele frequency of the SNP rs13361895 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs13361895 has an effect allele T frequency of 0.1276 and non-effect allele G frequency of 0.8724. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs13361895"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3552788', 'SNP': 'rs13361895', 'effect_allele': 'T', 'effect_allele_frequency': 0.1276, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.8724000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.73 | Q2 | What is the allele frequency of the SNP rs13396100 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs13396100 has an effect allele A frequency of 0.4078 and non-effect allele T frequency of 0.5922. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs13396100"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_270812', 'SNP': 'rs13396100', 'effect_allele': 'A', 'effect_allele_frequency': 0.4078, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.5922000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.435 | Q2 | What is the allele frequency of the SNP rs113097720 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs113097720 has an effect allele A frequency of 0.0330 and non-effect allele G frequency of 0.9670. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs113097720"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1551309', 'SNP': 'rs113097720', 'effect_allele': 'A', 'effect_allele_frequency': 0.033, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.967}] | general | Calculate, Select | Allele Frequency |
Q2.911 | Q2 | What is the allele frequency of the SNP rs76987095 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs76987095 has an effect allele A frequency of 0.0649 and non-effect allele T frequency of 0.9351. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs76987095"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3526695', 'SNP': 'rs76987095', 'effect_allele': 'A', 'effect_allele_frequency': 0.0649, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9351}] | general | Calculate, Select | Allele Frequency |
Q2.922 | Q2 | What is the allele frequency of the SNP rs79192032 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs79192032 has an effect allele T frequency of 0.0871 and non-effect allele C frequency of 0.9129. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs79192032"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3549507', 'SNP': 'rs79192032', 'effect_allele': 'T', 'effect_allele_frequency': 0.0871, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9129}] | general | Calculate, Select | Allele Frequency |
Q2.1679 | Q2 | What is the allele frequency of the SNP rs9320839 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs9320839 has an effect allele G frequency of 0.4956 and non-effect allele C frequency of 0.5044. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs9320839"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6538177', 'SNP': 'rs9320839', 'effect_allele': 'G', 'effect_allele_frequency': 0.4956, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.5044}] | general | Calculate, Select | Allele Frequency |
Q2.1272 | Q2 | What is the allele frequency of the SNP rs13382906 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs13382906 has an effect allele C frequency of 0.0192 and non-effect allele T frequency of 0.9808. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs13382906"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4973847', 'SNP': 'rs13382906', 'effect_allele': 'C', 'effect_allele_frequency': 0.0191999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9808000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1094 | Q2 | What is the allele frequency of the SNP rs9308842 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs9308842 has an effect allele T frequency of 0.2248 and non-effect allele A frequency of 0.7752. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs9308842"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4220061', 'SNP': 'rs9308842', 'effect_allele': 'T', 'effect_allele_frequency': 0.2248, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.7752}] | general | Calculate, Select | Allele Frequency |
Q2.389 | Q2 | What is the allele frequency of the SNP rs2824332 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2824332 has an effect allele T frequency of 0.2241 and non-effect allele C frequency of 0.7759. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs2824332"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1447010', 'SNP': 'rs2824332', 'effect_allele': 'T', 'effect_allele_frequency': 0.2241, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.7759}] | general | Calculate, Select | Allele Frequency |
Q2.841 | Q2 | What is the allele frequency of the SNP rs6957369 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs6957369 has an effect allele A frequency of 0.3587 and non-effect allele C frequency of 0.6413. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs6957369"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3242237', 'SNP': 'rs6957369', 'effect_allele': 'A', 'effect_allele_frequency': 0.3587, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.6413}] | general | Calculate, Select | Allele Frequency |
Q2.774 | Q2 | What is the allele frequency of the SNP rs73842212 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs73842212 has an effect allele G frequency of 0.0611 and non-effect allele A frequency of 0.9389. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs73842212"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_2967055', 'SNP': 'rs73842212', 'effect_allele': 'G', 'effect_allele_frequency': 0.0611, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9389}] | general | Calculate, Select | Allele Frequency |
Q2.1805 | Q2 | What is the allele frequency of the SNP rs62127003 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs62127003 has an effect allele C frequency of 0.0953 and non-effect allele T frequency of 0.9047. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs62127003"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7011553', 'SNP': 'rs62127003', 'effect_allele': 'C', 'effect_allele_frequency': 0.0953, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9047000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1992 | Q2 | What is the allele frequency of the SNP rs11744670 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs11744670 has an effect allele A frequency of 0.3359 and non-effect allele C frequency of 0.6641. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs11744670"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7736937', 'SNP': 'rs11744670', 'effect_allele': 'A', 'effect_allele_frequency': 0.3359, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.6641}] | general | Calculate, Select | Allele Frequency |
Q2.1066 | Q2 | What is the allele frequency of the SNP rs11669700 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs11669700 has an effect allele A frequency of 0.3416 and non-effect allele G frequency of 0.6584. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs11669700"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4119144', 'SNP': 'rs11669700', 'effect_allele': 'A', 'effect_allele_frequency': 0.3416, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.6584}] | general | Calculate, Select | Allele Frequency |
Q2.58 | Q2 | What is the allele frequency of the SNP rs632222 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs632222 has an effect allele G frequency of 0.3049 and non-effect allele A frequency of 0.6951. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs632222"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_203207', 'SNP': 'rs632222', 'effect_allele': 'G', 'effect_allele_frequency': 0.3048999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.6951}] | general | Calculate, Select | Allele Frequency |
Q2.1688 | Q2 | What is the allele frequency of the SNP rs67404702 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs67404702 has an effect allele G frequency of 0.1697 and non-effect allele A frequency of 0.8303. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs67404702"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6608504', 'SNP': 'rs67404702', 'effect_allele': 'G', 'effect_allele_frequency': 0.1696999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.8303}] | general | Calculate, Select | Allele Frequency |
Q2.1955 | Q2 | What is the allele frequency of the SNP rs2466486 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2466486 has an effect allele A frequency of 0.4374 and non-effect allele G frequency of 0.5626. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs2466486"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7635045', 'SNP': 'rs2466486', 'effect_allele': 'A', 'effect_allele_frequency': 0.4374, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.5626}] | general | Calculate, Select | Allele Frequency |
Q2.1218 | Q2 | What is the allele frequency of the SNP rs571754876 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs571754876 has an effect allele T frequency of 0.0335 and non-effect allele C frequency of 0.9665. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs571754876"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4739695', 'SNP': 'rs571754876', 'effect_allele': 'T', 'effect_allele_frequency': 0.0335, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9665}] | general | Calculate, Select | Allele Frequency |
Q2.1680 | Q2 | What is the allele frequency of the SNP rs6788256 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs6788256 has an effect allele G frequency of 0.0580 and non-effect allele A frequency of 0.9420. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs6788256"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6541313', 'SNP': 'rs6788256', 'effect_allele': 'G', 'effect_allele_frequency': 0.058, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.942}] | general | Calculate, Select | Allele Frequency |
Q2.1975 | Q2 | What is the allele frequency of the SNP rs113212494 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs113212494 has an effect allele G frequency of 0.0229 and non-effect allele A frequency of 0.9771. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs113212494"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7704827', 'SNP': 'rs113212494', 'effect_allele': 'G', 'effect_allele_frequency': 0.0229, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9771}] | general | Calculate, Select | Allele Frequency |
Q2.213 | Q2 | What is the allele frequency of the SNP rs76728585 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs76728585 has an effect allele G frequency of 0.0200 and non-effect allele A frequency of 0.9800. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs76728585"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_794431', 'SNP': 'rs76728585', 'effect_allele': 'G', 'effect_allele_frequency': 0.02, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.98}] | general | Calculate, Select | Allele Frequency |
Q2.1534 | Q2 | What is the allele frequency of the SNP rs148667066 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs148667066 has an effect allele A frequency of 0.0431 and non-effect allele G frequency of 0.9569. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs148667066"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5912807', 'SNP': 'rs148667066', 'effect_allele': 'A', 'effect_allele_frequency': 0.0431, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9569}] | general | Calculate, Select | Allele Frequency |
Q2.1135 | Q2 | What is the allele frequency of the SNP rs73512840 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs73512840 has an effect allele C frequency of 0.0313 and non-effect allele G frequency of 0.9687. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs73512840"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4356495', 'SNP': 'rs73512840', 'effect_allele': 'C', 'effect_allele_frequency': 0.0313, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9687}] | general | Calculate, Select | Allele Frequency |
Q2.131 | Q2 | What is the allele frequency of the SNP rs133493 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs133493 has an effect allele T frequency of 0.0601 and non-effect allele C frequency of 0.9399. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs133493"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_478609', 'SNP': 'rs133493', 'effect_allele': 'T', 'effect_allele_frequency': 0.0601, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9399}] | general | Calculate, Select | Allele Frequency |
Q2.819 | Q2 | What is the allele frequency of the SNP rs12078724 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs12078724 has an effect allele G frequency of 0.0123 and non-effect allele A frequency of 0.9877. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs12078724"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3164102', 'SNP': 'rs12078724', 'effect_allele': 'G', 'effect_allele_frequency': 0.0122999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9877000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1282 | Q2 | What is the allele frequency of the SNP rs28613001 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs28613001 has an effect allele T frequency of 0.0687 and non-effect allele C frequency of 0.9313. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs28613001"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5021233', 'SNP': 'rs28613001', 'effect_allele': 'T', 'effect_allele_frequency': 0.0687, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9313}] | general | Calculate, Select | Allele Frequency |
Q2.1872 | Q2 | What is the allele frequency of the SNP rs275517 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs275517 has an effect allele T frequency of 0.2707 and non-effect allele G frequency of 0.7293. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs275517"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7277829', 'SNP': 'rs275517', 'effect_allele': 'T', 'effect_allele_frequency': 0.2707, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.7293000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.438 | Q2 | What is the allele frequency of the SNP rs34466453 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs34466453 has an effect allele C frequency of 0.0565 and non-effect allele T frequency of 0.9435. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs34466453"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1564653', 'SNP': 'rs34466453', 'effect_allele': 'C', 'effect_allele_frequency': 0.0564999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9435000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.417 | Q2 | What is the allele frequency of the SNP rs9364358 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs9364358 has an effect allele A frequency of 0.2484 and non-effect allele C frequency of 0.7516. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs9364358"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1512230', 'SNP': 'rs9364358', 'effect_allele': 'A', 'effect_allele_frequency': 0.2484, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.7516}] | general | Calculate, Select | Allele Frequency |
Q2.1504 | Q2 | What is the allele frequency of the SNP rs201019393 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs201019393 has an effect allele T frequency of 0.1567 and non-effect allele A frequency of 0.8433. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs201019393"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5787868', 'SNP': 'rs201019393', 'effect_allele': 'T', 'effect_allele_frequency': 0.1566999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.8433000000000002}] | general | Calculate, Select | Allele Frequency |
Q2.234 | Q2 | What is the allele frequency of the SNP rs75185323 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs75185323 has an effect allele C frequency of 0.0518 and non-effect allele T frequency of 0.9482. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs75185323"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_858870', 'SNP': 'rs75185323', 'effect_allele': 'C', 'effect_allele_frequency': 0.0517999999999999, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.9482000000000002}] | general | Calculate, Select | Allele Frequency |
Q2.1708 | Q2 | What is the allele frequency of the SNP rs11760100 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs11760100 has an effect allele C frequency of 0.1048 and non-effect allele G frequency of 0.8952. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs11760100"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6674464', 'SNP': 'rs11760100', 'effect_allele': 'C', 'effect_allele_frequency': 0.1048, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.8952}] | general | Calculate, Select | Allele Frequency |
Q2.895 | Q2 | What is the allele frequency of the SNP rs141832036 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs141832036 has an effect allele C frequency of 0.0624 and non-effect allele G frequency of 0.9376. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs141832036"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3442020', 'SNP': 'rs141832036', 'effect_allele': 'C', 'effect_allele_frequency': 0.0624, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9376}] | general | Calculate, Select | Allele Frequency |
Q2.1625 | Q2 | What is the allele frequency of the SNP rs2518167 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2518167 has an effect allele A frequency of 0.3204 and non-effect allele T frequency of 0.6796. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs2518167"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6331414', 'SNP': 'rs2518167', 'effect_allele': 'A', 'effect_allele_frequency': 0.3204, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.6796}] | general | Calculate, Select | Allele Frequency |
Q2.699 | Q2 | What is the allele frequency of the SNP rs7770330 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs7770330 has an effect allele C frequency of 0.3036 and non-effect allele T frequency of 0.6964. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs7770330"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_2681773', 'SNP': 'rs7770330', 'effect_allele': 'C', 'effect_allele_frequency': 0.3036, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.6964}] | general | Calculate, Select | Allele Frequency |
Q2.1769 | Q2 | What is the allele frequency of the SNP rs77925770 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs77925770 has an effect allele T frequency of 0.0766 and non-effect allele C frequency of 0.9234. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs77925770"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6890118', 'SNP': 'rs77925770', 'effect_allele': 'T', 'effect_allele_frequency': 0.0766, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9234}] | general | Calculate, Select | Allele Frequency |
Q2.301 | Q2 | What is the allele frequency of the SNP rs7236361 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs7236361 has an effect allele T frequency of 0.0253 and non-effect allele A frequency of 0.9747. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs7236361"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1117956', 'SNP': 'rs7236361', 'effect_allele': 'T', 'effect_allele_frequency': 0.0252999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9747000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1399 | Q2 | What is the allele frequency of the SNP rs1922589 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs1922589 has an effect allele G frequency of 0.1814 and non-effect allele A frequency of 0.8186. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs1922589"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5415757', 'SNP': 'rs1922589', 'effect_allele': 'G', 'effect_allele_frequency': 0.1814, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.8186}] | general | Calculate, Select | Allele Frequency |
Q2.1987 | Q2 | What is the allele frequency of the SNP rs9265519 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs9265519 has an effect allele A frequency of 0.4447 and non-effect allele G frequency of 0.5553. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs9265519"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7727309', 'SNP': 'rs9265519', 'effect_allele': 'A', 'effect_allele_frequency': 0.4447, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.5553}] | general | Calculate, Select | Allele Frequency |
Q2.102 | Q2 | What is the allele frequency of the SNP rs4917902 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs4917902 has an effect allele C frequency of 0.2155 and non-effect allele G frequency of 0.7845. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs4917902"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_369141', 'SNP': 'rs4917902', 'effect_allele': 'C', 'effect_allele_frequency': 0.2155, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.7845}] | general | Calculate, Select | Allele Frequency |
Q2.831 | Q2 | What is the allele frequency of the SNP rs60793280 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs60793280 has an effect allele T frequency of 0.0365 and non-effect allele C frequency of 0.9635. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs60793280"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3218178', 'SNP': 'rs60793280', 'effect_allele': 'T', 'effect_allele_frequency': 0.0365, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9635}] | general | Calculate, Select | Allele Frequency |
Q2.359 | Q2 | What is the allele frequency of the SNP rs79151477 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs79151477 has an effect allele A frequency of 0.0180 and non-effect allele C frequency of 0.9820. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs79151477"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1300063', 'SNP': 'rs79151477', 'effect_allele': 'A', 'effect_allele_frequency': 0.018, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.982}] | general | Calculate, Select | Allele Frequency |
Q2.114 | Q2 | What is the allele frequency of the SNP rs980720 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs980720 has an effect allele T frequency of 0.1074 and non-effect allele C frequency of 0.8926. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs980720"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_430580', 'SNP': 'rs980720', 'effect_allele': 'T', 'effect_allele_frequency': 0.1074, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.8926000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.1440 | Q2 | What is the allele frequency of the SNP rs73456059 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs73456059 has an effect allele C frequency of 0.0674 and non-effect allele G frequency of 0.9326. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs73456059"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5567991', 'SNP': 'rs73456059', 'effect_allele': 'C', 'effect_allele_frequency': 0.0674, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.9326}] | general | Calculate, Select | Allele Frequency |
Q2.1840 | Q2 | What is the allele frequency of the SNP rs12896106 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs12896106 has an effect allele C frequency of 0.3958 and non-effect allele T frequency of 0.6042. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs12896106"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_7176019', 'SNP': 'rs12896106', 'effect_allele': 'C', 'effect_allele_frequency': 0.3958, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.6042000000000001}] | general | Calculate, Select | Allele Frequency |
Q2.952 | Q2 | What is the allele frequency of the SNP rs57926772 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs57926772 has an effect allele T frequency of 0.3913 and non-effect allele G frequency of 0.6087. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs57926772"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3660541', 'SNP': 'rs57926772', 'effect_allele': 'T', 'effect_allele_frequency': 0.3913, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.6087}] | general | Calculate, Select | Allele Frequency |
Q2.1186 | Q2 | What is the allele frequency of the SNP rs116948790 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs116948790 has an effect allele A frequency of 0.0339 and non-effect allele C frequency of 0.9661. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs116948790"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_4625765', 'SNP': 'rs116948790', 'effect_allele': 'A', 'effect_allele_frequency': 0.0339, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9661}] | general | Calculate, Select | Allele Frequency |
Q2.456 | Q2 | What is the allele frequency of the SNP rs1133763 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs1133763 has an effect allele C frequency of 0.1517 and non-effect allele A frequency of 0.8483. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs1133763"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_1617614', 'SNP': 'rs1133763', 'effect_allele': 'C', 'effect_allele_frequency': 0.1516999999999999, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.8483}] | general | Calculate, Select | Allele Frequency |
Q2.876 | Q2 | What is the allele frequency of the SNP rs144170143 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs144170143 has an effect allele T frequency of 0.0234 and non-effect allele C frequency of 0.9766. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs144170143"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_3389621', 'SNP': 'rs144170143', 'effect_allele': 'T', 'effect_allele_frequency': 0.0234, 'non_effect_allele': 'C', 'non_effect_allele_frequency': 0.9766}] | general | Calculate, Select | Allele Frequency |
Q2.1545 | Q2 | What is the allele frequency of the SNP rs6456677 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs6456677 has an effect allele G frequency of 0.0119 and non-effect allele A frequency of 0.9881. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs6456677"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5947853', 'SNP': 'rs6456677', 'effect_allele': 'G', 'effect_allele_frequency': 0.0119, 'non_effect_allele': 'A', 'non_effect_allele_frequency': 0.9881}] | general | Calculate, Select | Allele Frequency |
Q2.1701 | Q2 | What is the allele frequency of the SNP rs2890869 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2890869 has an effect allele C frequency of 0.2946 and non-effect allele T frequency of 0.7054. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs2890869"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_6660255', 'SNP': 'rs2890869', 'effect_allele': 'C', 'effect_allele_frequency': 0.2946, 'non_effect_allele': 'T', 'non_effect_allele_frequency': 0.7054}] | general | Calculate, Select | Allele Frequency |
Q2.1436 | Q2 | What is the allele frequency of the SNP rs6061521 in a Parkinson's Disease study involving a European cohort? | According to the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs6061521 has an effect allele A frequency of 0.4390 and non-effect allele G frequency of 0.5610. | SELECT UUID, SNP, A1 AS effect_allele, freq AS effect_allele_frequency, A2 AS non_effect_allele, 1-freq AS non_effect_allele_frequency
FROM `{project_id}.{dataset_name}.ParkinsonDisease_CompleteGeneData_No23andMe`
WHERE SNP = "rs6061521"
LIMIT 100 | [{'UUID': 'PDno23andme_full_gene_notext_5549373', 'SNP': 'rs6061521', 'effect_allele': 'A', 'effect_allele_frequency': 0.439, 'non_effect_allele': 'G', 'non_effect_allele_frequency': 0.5609999999999999}] | general | Calculate, Select | Allele Frequency |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.